Cell death & disease · 2026
Caspase-3 regulates RNA splicing and mitochondrial dynamics in microglia during Parkinson's disease.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Medina-Guzmán Rafael, Bahatyrevich-Kharitonik Bazhena, St-Pierre Marie-Kim, Márquez-Pérez Sara, Gavilán Elena, Coronel-Guisado Cristóbal, Flores-Cortes Alicia, García-Valiente Rodrigo, Argüelles Sandro, Kavanagh Edel, Yang Yiyi, Deierborg Tomas, Venero José Luis, González-Aguilera Cristina, Joseph Bertrand, Burguillos Miguel Ángel
Аннотация
Caspase-3, a cysteine-aspartic protease canonically known for its role in apoptotic cell death, has been implicated in several non-apoptotic functions, particularly in microglia, the brain-resident macrophages. These novel functions appear to depend on distinct levels of caspase-3 activation; however, the role of basal caspase-3 activity remains unclear. Here, we show that basal caspase-3 regulates RNA splicing in microglia, and its deficiency in a Parkinson´s disease (PD) model leads to splicing dysregulation. Loss of basal caspase-3 activity also increases double-stranded RNA (dsRNA) accumulation, inducing a type I interferon response. Additionally, caspase-3 deficiency impairs mitochondrial respiration, reduces ATP production, and causes sex-specific mitochondrial abnormalities, predominantly in female microglia. Together, our findings uncover a non-apoptotic, homeostatic role for basal caspase-3 activity in microglia. Its disruption, such as in PD, may drive key molecular features of neuroinflammation and neurodegeneration, positioning caspase-3 as a critical regulator of microglial function in health and disease.